Zydus Wellness Ltd Q4 FY2023 Concall Summary

Key Takeaways

• Gradual recovery, weather a spoiler: Net sales grew 11.8% YoY despite inclement March weather, with rural demand appearing to bottom out and urban staying ahead.
• Gross margin gap closing: Price hikes taken in the prior quarter helped Q4 catch up to last year's gross margins, but the company is still chasing FY21 levels and will take further increases.
• One-off costs hit the P&L: Other expenses jumped 36%, nearly half of it one-time, driven by temporary third-party manufacturing for Glucon-D after the Sitarganj plant shutdown and high alternative fuel and labour inflation.
• Complan remains the margin problem child: The health food drinks category slowed and Complan is the most challenged product on gross margins, with milk inflation a persistent headwind.
• What to watch next quarter: Whether the summer season delivers after a weak March-April start, how quickly the one-off manufacturing costs roll off, and any price action on Complan.

Demand & Volume Environment

• Rural green shoots, urban steady: Urban demand continued to outperform rural, but management believes the rural slowdown has bottomed out and expects recovery ahead. Downtrading toward lower-unit packs was visible in rural markets.
• Weather disrupted the summer start: March and April saw inclement weather across the country, muting the early summer season. Pipeline fill was healthy, but offtake depends on how the rest of the season plays out.
• Volume visibility is low: Full-year volume growth was 4.8%, but management declined to give a quarterly split or near-term forecast, citing weather volatility and uncertain consumer spending recovery.

Management: "Hard to guess how the whole thing will shape up because the weather is a very, very volatile thing, and it just changes every week, especially in summer."

Brand-Level Performance

Margin & Cost Structure

• Gross margin recovery is a two-step story: Price hikes of 6.5% taken in the prior quarter closed the YoY gap for Q4. However, inflation since FY21 has not been fully passed on, and further price increases are planned over the next few quarters to reclaim those levels.
• Other expenses spiked on temporary factors: The 36% YoY increase was driven by high alternative fuel and labour costs, plus temporary outsourcing of Glucon-D manufacturing after the Sitarganj plant was shut. Nearly half the increase is one-time and will not repeat.
• Complan is the margin drag: Among the portfolio, Complan faces the steepest gross margin challenge. Milk prices remain elevated in India, though international Complan operations benefit from falling milk prices in sourcing markets like New Zealand.
• The 20% operating margin ambition is distant: Management was explicit that getting back to FY21 gross margins comes first; only then will scale and operating leverage push operating margins toward the target. The journey will take a longer period of time.
• Ad spend will rise when margins allow: Ad and sales promotion spend came down in FY23 to protect the P&L. Management wants to push it back to the 12.5-13% range once gross margins can afford it.

Management: "It will take some time for us to get there because gap in gross margin itself is substantial. We first want to get our gross margins back with the scale, obviously, and with operating leverage, we should get that. So it will take a longer period of time."

Distribution & Digital Initiatives

• Field force fully digitized: 100% of the field force is now on an automation platform, enabling sharper SKU-level selling, better targeting by store type and market, and improved efficiency.
• Reach ambition set: The company plans to expand overall reach to 0.3 crore outlets over the next 2 to 3 years, with city-by-city planning based on data and brand traction to target specific geographies and opportunities.
• Back-end planning upgraded: Digital efforts are also focused on operations planning for stronger inventory management.

Management: "Now our focus, just to close that, will be more to drive overall reach over the next 2 to 3 years to 0.3 crore outlets. And that, I think, will give us much better outcomes."

Innovation & Portfolio Moves

• Innovation bar is set at new benefits: New products are defined as those with new technology or a new consumer benefit, not line extensions or flavour variants. The pipeline balances substantive innovation with platform innovation.
• Launches span formats and flavours: During the year, the company launched sachets, Kaccha Mango under Immunovolt, and a mango variant in flavoured glucose powder.
• Go-to-market discipline: New launches follow a structured process covering distribution targets, repeat purchase metrics, and brand acceptance tracking, with course corrections possible after the first year. Simulated test market results played out in actual market execution.
• Sugarlite legal overhang: The company has appealed to a higher court on the Sugarlite brand issue and expects resolution as the process moves forward.

Guidance & Commitments

Key Metrics